This Programme is quite unique in that it is not intended for biomedical students pursuing a Ph.D. in regenerative medicine or related subjects. In our opinion, there are plenty of postgraduate programmes at European universities that fill that knowledge area. As an alternative, the target audience for this pioneering Master's programme are the professionals presently working (or intending to do so) in Good Manufacturing Practice (GMP)-compliant facilities producing cell therapy, gene therapy or tissue engineered products for human use. In other words, we are targeting the technologists who will develop advanced therapy medicinal products (ATMPs) in different laboratories and institutions - be it hospitals, academia or industry - within Europe, such as:

> Technical Directors or Qualified Persons of ATMP's Pharmaceutical Laboratories

> Manufacturing Managers of ATMP's Pharmaceutical Laboratories

> Quality Control Managers of ATMP's Pharmaceutical Laboratories

> Quality Assurance Managers of ATMP's Pharmaceutical Laboratories

Other potential attendees are professionals from diverse backgrounds who wish to update their knowledge related to any of our theoretical sections or who are seeking to enter the advanced therapy sector, or academic institutions and other public employees seeking to acquire a deep understanding of the sector that was once the preserve of the pharmaceutical industry. 

The University-Specific Degrees we are offering are:

> Master Degree in Manufacturing of Advanced Therapy Medicinal Products (1,500 hours / 60 ECTs)

> Specialisation Degree in Manufacturing of Advanced Therapy Medicinal Products (970 hours / 38.80 ECTs)

Click here to see the requirements for applying to the degrees and the tuition fees